Showing results (191-200 of 203) with videos related to
Sort By:
Pageof 21
Plos One|November 16, 2013
Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trialOliver Laeyendecker, Michal Kulich, Deborah Donnell, et al.BMJ Open|August 28, 2023
Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trialSharana Mahomed, Nigel Garrett, Disebo Potloane, et al.Nature Communications|December 6, 2023
Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariantKhadija Khan, Gila Lustig, Cornelius Römer, et al.Plos Medicine|January 23, 2015
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysisCharles S Morrison, Pai-Lien Chen, Cynthia Kwok, et al.Science Translational Medicine|January 26, 2018
Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomesAida Sivro, Alexandra Schuetz, Daniel Sheward, et al.Plos Medicine|June 8, 2021
Ending AIDS as a public health threat by 2030: Time to reset targets for 2025Paul R De Lay, Adèle Benzaken, Quarraisha Abdool Karim, et al.Nature Communications|August 10, 2022
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infectionKhadija Khan, Farina Karim, Yashica Ganga, et al.Nature Communications|March 16, 2024
Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiationFarina Karim, Catherine Riou, Mallory Bernstein, et al.Nature|May 6, 2022
Omicron infection enhances Delta antibody immunity in vaccinated personsKhadija Khan, Farina Karim, Sandile Cele, et al.Plos Pathogens|July 20, 2016
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive ImmunizationCecilia Rademeyer, Bette Korber, Michael S Seaman, et al.Pageof 21